Table 4 Laboratory values: Change from baseline

From: Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes

Lab parameters

Baseline Mean ± SD

Follow up Mean ± SD

Mean change (± SD)

P value

Triglycerides (mg/dL)

346.78 ± 246.01

154.00 ± 127.73

−192.78 [±91.06]

0.0001

Non HDLc (mg/dL)

157.34 ± 53.44

108.63 ± 34.47

−48.72 [±17.09]

<0.0001

LDLc (mg/dL)

108.34 ± 46.94

84.31 ± 23.26

−24.04 [±16.14]

0.0048

Total Cholesterol (mg/dL)

195.91 ± 56.97

147.75 ± 36.08

−48.16 [±17.32]

<0.0001

HDLc (mg/dL)

38.88 ± 9.79

39.34 ± 11.37

+0.47 [±3.45]

0.7836

TG/HDL ratio

9.60 ± 7.84

4.30 ± 4.12

−5.30 [±2.82]

0.0006

FPG (mg/dL)

160.53 ± 53.71

123.82 ± 54.91

−36.71 [±20.06]

0.0007

PPG (mg/dL)

243.68 ± 114.59

177.39 ± 60.87

−66.29 [±34.71]

0.0005

HbA1c (%)

8.34 ± 1.58

7.21 ± 1.33

−1.13 [±0.43]

<0.0001

Back to article page